Medical debulking with BRAF/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma
Academic Article
Publication Date:
2020
Short description:
Medical debulking with BRAF/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma / Di Stefano, A.L., Guyon, D., Sejean, K., Feuvret, L., Villa, C., Berzero, G., Desforges Bullet, V., Halimi, E., Boulin, A., Baussart, B., Gaillard, S.. - In: NEURO-ONCOLOGY ADVANCES. - ISSN 2632-2498. - 2:1(2020). [10.1093/noajnl/vdaa141]
abstract:
BRAF-activating mutations have been detected in nearly all craniopharyngiomas of the papillary subtype, with interesting implications for patients with suboptimal tumor control. Here we report that combined treatment with BRAF and MEK inhibitors resulted in major clinical benefit in the case of a patient with a BRAF V600E-mutant papillary craniopharyngioma rapidly progressing after surgery.
Iris type:
1.1 Articolo in rivista
List of contributors:
Di Stefano, A. L.; Guyon, D.; Sejean, K.; Feuvret, L.; Villa, C.; Berzero, G.; Desforges Bullet, V.; Halimi, E.; Boulin, A.; Baussart, B.; Gaillard, S.
Published in: